公司資料
Hoth Therapeutics 股價、新聞與催化劑
- 股票代碼:
- HOTH
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
1.36 USD (+92.01%)
收盤價
最後更新: 2026年5月27日
26M USD
市值
股價為何變動
目前無法取得 HOTH 的收盤價變動背景。
公司概覽
業務概覽
Hoth Therapeutics is a biotechnology company focused on developing therapies across dermatology, inflammation, and oncology. Its story is built around a broad but still early-stage development portfolio.
所在地與產業分類
Hoth is headquartered in the United States and listed on NASDAQ. It sits in small-cap specialty biopharma.
商業模式特徵
The company depends on preclinical and early clinical progress, capital efficiency, and the ability to prioritize programs. Investors usually watch proof-of-concept data and strategic changes.
生技產業定位
Hoth occupies a speculative small-cap biotech niche. Its stock tends to move on program updates because the company is still shaping its identity.
未來催化劑
- Hoth’s catalysts are its dermatology and inflammatory-disease programs, plus any strategic update that clarifies which assets still matter. The market will care about whether the company can keep a viable development path.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。